title: A classification system for cross-reactive material-negative factor XI deficiency.
abstract: The bleeding disorder associated with factor XI (fXI) deficiency is typically inherited as an autosomal recessive trait. However, some fXI mutations may be associated with dominant disease transmission. FXI is a homodimer, a feature that could allow certain mutations to exert a dominant-negative effect on wild-type fXI secretion through heterodimer formation. We describe 2 novel fXI mutations (Ser225Phe and Cys398Tyr) that form intracellular dimers, are secreted poorly, and exhibit dominant-negative effects on wild-type fXI secretion in cotransfection experiments. Available data now suggest that mutations associated with crossreactive material-negative fXI deficiency fall into 1 of 3 mechanistic categories: (1) mutations that reduce or prevent polypeptide synthesis, (2) polypeptides that fail to form intracellular dimers and are retained in cells as monomers, and (3) polypeptides that form dimers that are not secreted. The latter category likely accounts for many cases of dominant disease transmission.
authors.affiliation: Department of Pathology, Vanderbilt University, Nashville, TN 37232-6307, USA.
authors.forename: Dmitri V
authors.initials: DV
authors.lastname: Kravtsov
authors.forename: Paul E
authors.initials: PE
authors.lastname: Monahan
authors.forename: David
authors.initials: D
authors.lastname: Gailani
mesh_terms: D000328:Adult; D000483:Alleles; D000818:Animals; D015153:Blotting, Western; D002460:Cell Line; D006224:Cricetinae; D004247:DNA / Q000378:metabolism; D019281:Dimerization; D005091:Exons; D005172:Factor XI / Q000235:genetics; D005173:Factor XI Deficiency / Q000145:classification* / Q000175:diagnosis*; D005260:Female; D005347:Fibroblasts / Q000378:metabolism; D005799:Genes, Dominant; D006579:Heterozygote; D006801:Humans; D008297:Male; D008954:Models, Biological; D009154:Mutation; D010455:Peptides / Q000737:chemistry; D017354:Point Mutation; D017422:Sequence Analysis, DNA; D014162:Transfection
chemical_list: D010455:Peptides; D004247:DNA; D005172:Factor XI
references.citation: Br J Haematol. 1988 Aug;69(4):521-8
references.pmid: 3408688
references.citation: Am J Hematol. 1988 May;28(1):8-12
references.pmid: 3369441
references.citation: Biochemistry. 1991 Feb 26;30(8):2056-60
references.pmid: 1998667
references.citation: N Engl J Med. 1991 Jul 18;325(3):153-8
references.pmid: 2052060
references.citation: Biochemistry. 1991 Oct 29;30(43):10363-70
references.pmid: 1931959
references.citation: Blood. 1992 Mar 15;79(6):1435-40
references.pmid: 1547342
references.citation: Biochemistry. 1992 May 19;31(19):4680-4
references.pmid: 1581318
references.citation: Blood. 1997 Oct 1;90(7):2654-9
references.pmid: 9326232
references.citation: Hum Gene Ther. 1998 Oct 10;9(15):2263-75
references.pmid: 9794210
references.citation: AMA Arch Intern Med. 1957 Aug;100(2):232-40
references.pmid: 13443544
references.citation: Blood. 1961 Aug;18:149-65
references.pmid: 13739555
references.citation: J Biol Chem. 1999 Dec 17;274(51):36373-8
references.pmid: 10593931
references.citation: Br J Haematol. 1999 Dec;107(4):763-5
references.pmid: 10606881
references.citation: Blood. 2000 Feb 15;95(4):1336-41
references.pmid: 10666208
references.citation: Blood. 2001 Nov 15;98(10):2973-9
references.pmid: 11698279
references.citation: Blood. 2004 Jul 1;104(1):128-34
references.pmid: 15026311
references.citation: J Biol Chem. 1977 Sep 25;252(18):6432-7
references.pmid: 893417
references.citation: J Lab Clin Med. 1985 Dec;106(6):718-22
references.pmid: 4067382
references.citation: Proc Natl Acad Sci U S A. 1989 Oct;86(20):7667-71
references.pmid: 2813350